These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 11771108

  • 1. [Evaluation of efficacy and safety of sterile solution of lodoxamide in patients with ocular allergy].
    Nicoară S.
    Oftalmologia; 2001; 52(2):81-4. PubMed ID: 11771108
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of the efficacy and safety of lodoxamide in patients with allergic eye diseases].
    Dekaris I, Gabrić N, Lazić R, Bosnar D, Cima I, Stipić A.
    Acta Med Croatica; 2002; 56(3):93-8. PubMed ID: 12630339
    [Abstract] [Full Text] [Related]

  • 3. A clinicopathological analysis of the efficacy of lodoxamide 0.1% eye drops on the conjunctiva of patients with vernal keratoconjunctivitis seen at Guinness Eye Centre, Lagos University Teaching Hospital.
    Adefule-Ositelu AO, Onakoya AO, Olasimbo OO, Adefule AK.
    Niger Postgrad Med J; 2006 Mar; 13(1):35-40. PubMed ID: 16633377
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of lodoxamide in vernal keratoconjunctivitis.
    Das D, Khan M, Gul A, Alam R.
    J Pak Med Assoc; 2011 Mar; 61(3):239-41. PubMed ID: 21465936
    [Abstract] [Full Text] [Related]

  • 5. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.
    Denis D, Bloch-Michel E, Verin P, Sebastiani A, Tazartes M, Helleboid L, Di Giovanni A, Lecorvec M.
    Br J Ophthalmol; 1998 Oct; 82(10):1135-8. PubMed ID: 9924299
    [Abstract] [Full Text] [Related]

  • 6. Comparison of topical 0.05% levocabastine and 0.1% lodoxamide in patients with allergic conjunctivitis. Study Group.
    Richard C, Trinquand C, Bloch-Michel E.
    Eur J Ophthalmol; 1998 Oct; 8(4):207-16. PubMed ID: 9891891
    [Abstract] [Full Text] [Related]

  • 7. [An efficacy study of lodoxamide treatment in allergic eye lesions].
    Giuri S, Munteanu GH.
    Oftalmologia; 2000 Oct; 50(1):68-76. PubMed ID: 11021110
    [Abstract] [Full Text] [Related]

  • 8. Lodoxamide versus spaglumic acid: a comparative double-blind trial on patients suffering from seasonal allergic conjunctivitis induced by Parietaria pollen.
    Purello D'Ambrosio F, Gangemi S, Ricciardi L, Cuzzocrea S, Di Lorenzo G.
    Allergol Immunopathol (Madr); 1997 Oct; 25(5):233-7. PubMed ID: 9395007
    [Abstract] [Full Text] [Related]

  • 9. [Alomide eyedrops in the treatment of allergic conjunctivitis and keratoconjunctivitis].
    Maĭchuk IuF, Khaitova KN, Grishakova MB.
    Vestn Oftalmol; 1998 Oct; 114(4):43-4. PubMed ID: 9771090
    [Abstract] [Full Text] [Related]

  • 10. Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.
    Verin P, Allewaert R, Joyaux JC, Piozzi E, Koliopoulos J, Bloch-Michel E, Lodoxamide Study Group.
    Eur J Ophthalmol; 2001 Oct; 11(2):120-5. PubMed ID: 11456011
    [Abstract] [Full Text] [Related]

  • 11. A critical look at ocular allergy drugs.
    Joseph Titi M.
    Am Fam Physician; 1996 Jun; 53(8):2637-42, 2645-6. PubMed ID: 8644576
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms and comparison of anti-allergic efficacy of topical lodoxamide and cromolyn sodium treatment in vernal keratoconjunctivitis.
    Avunduk AM, Avunduk MC, Kapicioglu Z, Akyol N, Tavli L.
    Ophthalmology; 2000 Jul; 107(7):1333-7. PubMed ID: 10890862
    [Abstract] [Full Text] [Related]

  • 13. [Alomide, a preventive immunopharmaceutical agent, in the treatment of ocular atopy].
    Krásný J.
    Cesk Slov Oftalmol; 1998 Jan; 54(1):41-5. PubMed ID: 9501643
    [Abstract] [Full Text] [Related]

  • 14. Lodoxamide as adjuvant therapy in patients with dry eye.
    Petricek I, Pokupec R, Petricek G, Salopek-Rabatić J.
    Coll Antropol; 2001 Jan; 25 Suppl():149-52. PubMed ID: 11817007
    [Abstract] [Full Text] [Related]

  • 15. Randomised double-masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicentre study.
    Fahy GT, Easty DL, Collum LM, Benedict-Smith A, Hillery M, Parsons DG.
    Eur J Ophthalmol; 1992 Jan; 2(3):144-9. PubMed ID: 1450659
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of lodoxamide eye drops on tear fluid cytology of patients with vernal conjunctivitis.
    Oguz H, Bitiren M, Aslan OS, Ozardali I.
    Acta Med Okayama; 1999 Jun; 53(3):123-6. PubMed ID: 10410789
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis.
    Bonini S, Schiavone M, Bonini S, Magrini L, Lischetti P, Lambiase A, Bucci MG.
    Ophthalmology; 1997 May; 104(5):849-53. PubMed ID: 9160033
    [Abstract] [Full Text] [Related]

  • 18. Contrast of the effect of alomide and sodium cromoglycate in the treatment of allergic eye diseases.
    Zhang W, Lin Z.
    Yan Ke Xue Bao; 2000 Sep; 16(3):214-6. PubMed ID: 12579651
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the clinical efficacy of pheniramine maleate/naphazoline hydrochloride ophthalmic solution and olopatadine hydrochloride ophthalmic solution in the conjunctival allergen challenge model.
    Greiner JV, Udell IJ.
    Clin Ther; 2005 May; 27(5):568-77. PubMed ID: 15978305
    [Abstract] [Full Text] [Related]

  • 20. Lodoxamide treatment of allergic conjunctivitis.
    Cerqueti PM, Ricca V, Tosca MA, Buscaglia S, Ciprandi G.
    Int Arch Allergy Immunol; 1994 Oct; 105(2):185-9. PubMed ID: 7920019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.